Profile
Contact Information
Center Information
Shelly SearleSite Manager
Alliance for Multispecialty Research – Utah (formerly Pharmaceutical Research Organization)
1492 West Antelope Drive, Suite 209
Layton, Utah 84041
801.294.9911
Fax: 801.294.9922
Email: shelly.searle@amrllc.com
www.amrutah.com
Overview
AMR Utah, a trial management organization, offers a diverse arena of clinical trial capabilities including pediatric and adult outpatient and inpatient studies. We pride ourselves in delivering timely, accurate and reproducible results to sponsor companies and clinical research organizations. We insist on producing work of only the highest caliber. Sponsors and CROs can reach our administrative officers or any of our trained study coordinators 24 hours a day, seven days a week. Our goal is to make the entire clinical trial process smooth from beginning to end by placement, principal investigator recruitment and training, contract and budget negotiation, regulatory affairs, coordinator assignments, patient recruitment, data collection, quality assurance and compliance.
Mission: To conduct high quality clinical research in a respectful, professional, and efficient manner with patient safety and welfare at the forefront. We generate knowledge and information necessary for development of the medical cures and treatments of tomorrow while fostering an environment that encourages personal growth.
Vision: To become the largest, most respected, innovative, and highest quality clinical research company dedicated to improving worldwide health.
Core Values:
- Excellence & Consistency- We relentlessly pursue excellence in everything we do, every day. We improve our performance continuously and strive to be the best in everything we do. We satisfy real-life needs by combining best practices with unique ideas.
- Collaborative Innovation- We encourage cooperative efforts at every level and across all activities in our company, as well as nurture and support creativity and the development of new ideas, products and processes. We work closely together as one team to improve the way we do business every day. We communicate openly and establish clear accountability for making decisions, identifying issues and solutions, and maximizing business opportunities.
- Respect- Subjects, Sponsors, Team Members. We value our people, encourage their development, and reward their performance. Respect requires consideration and helpfulness; therefore, the act of listening is critical. We must all have the understanding and capacity for empathy to actively fulfill our core value of respect. We value all our customers, subjects, sponsors, and team members, for their diverse backgrounds, experience, styles, approaches, and ideas.
- Community- We conduct our business as responsible members of the communities in which we operate. We will work with our communities by volunteering, providing a safe workplace, and supporting likeminded endeavors.
- Unimpeachable Ethics- We always take the high road by practicing the highest of ethical standards and by honoring our commitments. We will take personal responsibility for our actions and treat everyone fairly and with trust and respect
Research Experience
AMR Utah has established relationships with a wide range of specialty practices. We will also recruit additional principal investigators and sites for almost any specialty or practice to meet sponsor requirements or protocol-specific needs, as well as place trained and research-dedicated study coordinators at those sites.
AMR Utah conducts mainly phase 2 to 4 clinical research protocols. For a more detailed listing of our clinical research experience, please visit our web page, www.amrutah.com.
Sponsors and CROs AMR Utah has contracted with include:
Sponsors
- 3M Pharmaceuticals
- Accelovance
- Access Pharmaceuticals
- Advancis Pharmaceutical
- Alcon Research
- Altana
- Amgen
- AstraZeneca
- Astellas
- Astellas Scientific and Medical Affairs
- Aventis Pasteur
- Bayer Consumer Care
- Bayer Pharmaceuticals
- BioSante Pharmaceuticals
- Boehringer Ingelheim Pharmaceuticals
- Bristol Myers Squibb
- Celltech Pharmaceuticals
- Dow Pharmaceutical Sciences
- Eli Lilly and Company/Reliant Pharmaceuticals
- Ferndale Laboratories
- Forest Laboratories
- G.D. Searle
- Genomics Collaborative
- GlaxoSmithKline Biologicals
- GlaxoSmithKline Group of Companies
- GlaxoWellcome
- Guilford Pharmaceuticals
- Hatchtech
- IBSA
- InSite Vision
- Janssen Pharmaceutical
- KV Pharmaceutical
- Labopharm
- Luitpold Pharmaceuticals
- MannKind
- MedImmune Vaccines
- Medivector
- Merck
- Merck KGaA
- Mesa Biotech
- Myriad Pharmaceuticals
- Novartis Pharmaceuticals
- Novan
- OrthoBiotech Products
- OrthoLogic
- Osel
- Otsuka Maryland Research Institute
- Perlegen Sciences
- Pfizer
- Pharmacia
- Sandoz
- Sanofi Pasteur
- Schering-Plough Research Institute
- SeraCare Life Sciences
- Shionogi
- Shire Pharmaceuticals Group
- SmithKline Beecham
- Solvay Pharmaceuticals
- Spear Pharmaceuticals
- Sucampo
- TEVA Pharmaceuticals USA
- Vertex Pharmaceuticals
- Watson Laboratories
CROs
- AAI Development Services
- B & B Clinical Innovations
- CareStat
- Chiltern International
- Clinical Research Group
- Clinical Trials Management Services
- Covalent Group
- Covance
- i3 Research
- Icon Clinical Research
- Ingenix Pharmaceutical Services
- Integrium
- Inveresk
- Kendle International
- Monitoring Force
- Norwich Clinical Research
Associates - Omnicare
- Ovation Research Group
- Parexel International Corporation
- PharmaNet
- The Phoenix
- PPD Development
- PRA International
- Premier Research
- Quintiles
- ReSearch Pharmaceutical Services,
- ResearchPoint
- Research Scientists
- SCIREX
- SFBC Charlotte
- SFBC New Drug Services
- Synteract
- Therapeutics
Clinical trial research experience by drug category
- Analgesic
- Antibiotic
- Antihistamine
- Anti-inflammatory
- Asthma
- Bacterio therapeutic
- Blood conservation
- Bone growth stimulator
- Bronchodilator
- Calcimimetic agent
- Central nervous system stimulant
(extended release) - Chloride channel activator
- Conscious sedation
- Contraceptive–injectable
- COVID-19 vaccine
- Hematinic
- Histamine H2–receptor antagonist
- Hormone replacement therapy - male
- Hormone replacement therapy - female
- IgE binder
- Immune response modifier
- Inhaled corticosteroid
- Intraocular pressure-lowering agent
- Leukotriene receptor antagonist
- Lipid-lowering agent
- Long-acting beta–adrenergic agonist
- Mucoadhesive patch
- Ocular antibiotic/steroid
- Ocular antibiotic
- Ocular hypotensive
- Ocular steroid
- Oral corticosteroid
- Pain research
- Pediculocide
- Plasmapheresis
- Quinolone antibiotic
- Red blood cell production stimulant
- Respiratory syncytial virus
- Serotonin receptor agonist
- Statin
- Synthetic inhaled corticosteroid
- Testosterone gel
- Topical antibiotic
- Topical corticosteroid
- Topical hormone gel
- Topical steroid
- Triptan
- Vaccine–concomitantly administered
- Vaccine–miscellaneous combinations
- Vaccine–pentavalent combinations
- Vaccine–quadravalent combinations
- Vaccine–rotavirus
- Vaccine–tetravalent combinations
- Vaccine–seasonal and H1N1 influenza
To date, AMR Utah has contracted with 90 pharmaceutical companies, 50 contract research organizations, more than 47 independent and private-practice principal investigators, and 30-plus investigative sites to conduct 450 research studies and enroll more than 16,000 patients throughout the states of Utah and Idaho.
Investigator Experience
Investigative sites include, but are not limited to, the following areas of specialty:
- Audiology
- Dentistry
- Dermatology
- Family practice
- Gastroenterology
- Geriatrics
- Hematology
- Internal medicine
- Immunology/infectious disease
- Nephrology
- Neurology
- Obstetrics and gynecology
- Ophthalmology
- Optometry
- Orthopedics
- Otolaryngology
- Pediatrics
- Pharmacology
- Public Health
- Sports Medicine
- Surgery
Staff Expertise
AMR Utah is comprised of trained coordinators with more than 40 years combined coordinator research experience.
A special note about our clinical research coordinators: Our coordinators are research-dedicated. They consist of mostly full-time and a few part-time employees. Their backgrounds include RN, LPN or CMA degrees as well as ACRP and SOCRA certifications. These research-trained and dedicated coordinators are placed at our investigational sites to assist the investigators in recruiting, screening, enrolling and gathering data on each of our contracted protocols to help ensure GCP/ICH compliance and high, quality enrollment.
Patient Demographics
Composition by race (site dependent):
Caucasian - 80 percent
African-American – 5 percent
Asian - 5 percent
Hispanic – 5 percent
Other – 5 percent
Composition by gender:
Male 50 percent
Female 50 percent
Other Information
AMR Utah uses a central IRB.